Resources
AAT-AD/PD™ focus meeting - Virtual conference
The AAT-AD/PD™ Focus Meeting 2020 will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.
A central theme will be to further advance innovative strategies in therapy and prevention, clinical trials and diagnostic markers discussed in the sessions and corridors at AD/PD™ 2019, in order to focus on driving successful collaborations among academia and industry, leading to the development of innovative therapies and ultimately providing for a better future for patients and families affected by neurodegenerative diseases.
Shares Investor Evening (London)
Join Shares and AJ Bell for an evening of investment inspiration and get to meet the decision-makers behind some of the UK’s fastest growing listed companies. The evening is a perfect opportunity for existing shareholders or potential investors to hear from the directors running the companies, being the individuals best placed to explain the strategy and opportunity for investors.
1st ARCA Global Conference - CANCELLED
The 1st conference of the ARCA Global network aims to advance a global consortium for translational studies in autosomal-recessive ataxias (ARCAs), ARCA Global. ARCA Global is a dynamic, collaborative translational research initiative ultimately aiming to prepare and conduct harmonized multi-center treatment trials in genetically stratified ARCAs, thus allowing to translate the recent progress in ARCA genetics directly into stringent targeted treatment trials. It will integrate all main stakeholder groups including basic and clinician scientists, industry, and patient organizations.
View
15th Annual Huntington's Disease Therapeutics Conference
Join us at the Parker Hotel in Palm Springs, California, to meet colleagues, share ideas, and make new connections in the pursuit of therapeutics for Huntington's disease.
View
SCOPE Summit for Clinical Ops Executives
Over the course of four stimulating days of in-depth discussions in 20 different conferences, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy and Analytics, Sensors and Wearables, Artificial Intelligence, Clinical Biomarker Strategy, Precision Medicine, Clinical Biomarkers, and an all new track on Medical Device Clinical Trial Operations and Regulations.
Growth & Innovation Forum
The show is brought to you by the team at Shares Magazine, in partnership with Cenkos Securities. The Growth and Innovation Forum connects top experts, who will share their in-depth knowledge of investing and meet directors from fast-growing and technology led London listed companies.
LSX World Congress 2020
For 5 years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science business strategy, investment, partnering, deal making and commercialisation.
LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly listed life science giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.
The industry’s c-suite will be joined by the sector’s most active investors, pharma and healthtech BD&L teams, key stakeholders and top tier service companies who are moving the sector forward.
14th Human Amyloid Imaging Conference
HAI 2020 will continue to emphasize ample lively discussion of core controversies such as: what does the presence of brain amyloid mean, how should it be measured, how does it change, and what does it portend? Our discussions primarily spring from brief presentations by active investigators who will report on unpublished, cutting-edge research in human imaging of amyloid-beta and/or other biomarkers that pertain to Alzheimer’s-related disease.
View105-112 of 133 results